Engineers Gate Manager LP Increases Stock Position in Agilent Technologies, Inc. $A

Key Points

• Engineers Gate Manager LP increased its Agilent Technologies position by 10.1% in the second quarter, adding 11,668 shares for a total holding of 126,957 shares valued at approximately $16.9 million.
• Agilent reported quarterly EPS of $1.62, beating estimates of $1.49, while revenue rose 8.1% year over year to $1.88 billion. The company issued fiscal 2026 EPS guidance of $6.18–$6.21.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $170.33, although Director Mikael Dolsten sold 634 shares at an average price of $151.38.

Engineers Gate Manager LP boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 10.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,957 shares of the medical research company's stock after buying an additional 11,668 shares during the quarter. Engineers Gate Manager LP's holdings in Agilent Technologies were worth $16,864,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in A. Core Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at about $26,000. SHP Wealth Management acquired a new stake in Agilent Technologies during the fourth quarter worth about $26,000. Navalign LLC purchased a new position in Agilent Technologies during the fourth quarter valued at approximately $27,000. Cedar Mountain Advisors LLC acquired a new position in Agilent Technologies in the first quarter valued at approximately $27,000. Finally, Markowski Investments acquired a new position in Agilent Technologies in the second quarter valued at approximately $27,000.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business's stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares of the company's stock, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Agilent Technologies Trading Down 1.4%

Shares of A stock opened at $144.79 on Thursday. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $163.75. The firm has a market cap of $40.82 billion, a PE ratio of 28.50, a price-to-earnings-growth ratio of 2.24 and a beta of 1.24. The company has a 50-day moving average of $143.14 and a two-hundred day moving average of $128.35. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the firm earned $1.37 EPS. The business's revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Analyst Upgrades and Downgrades

A has been the topic of several recent research reports. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Sunday, August 2nd. Barclays boosted their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an "overweight" rating in a research note on Thursday, August 27th. Morgan Stanley increased their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an "overweight" rating in a report on Wednesday, August 12th. Piper Sandler started coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a "neutral" rating and a $150.00 price target on the stock. Finally, Stifel Nicolaus lifted their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a "buy" rating in a report on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $170.33.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company's offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.